Thomas Bronson Hunter, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1230 Via Salerno, Winter Park, FL 32789 Phone: 407-645-1679 |
Dr. Jeffrey Michael Hartog, JEFFREY HARTOG M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4355 Bear Gully Rd, Winter Park, FL 32792 Phone: 407-678-3116 Fax: 321-282-0565 |
Joseph Barry Boyd, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 200 Benmore Dr, Winter Park, FL 32792 Phone: 407-645-2007 Fax: 407-645-4671 |
Dr. Scott A Greenberg, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1925 Mizell Ave, Suite 303, Winter Park, FL 32792 Phone: 407-644-3137 |
Dr. Thomas Patrick Trevisani Sr., MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2802 Aloma Ave, Ste 101, Winter Park, FL 32792 Phone: 407-629-4100 |
Mr. Frank H. Stieg Iii, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 851 W Morse Blvd, Winter Park, FL 32789 Phone: 407-647-4601 Fax: 407-647-7353 |
Dr. Clifford P Clark Iii, M.D., P.A. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 701 W Morse Blvd, Winter Park, FL 32789 Phone: 407-629-5555 Fax: 407-629-4884 |
News Archive
ChipDX LLC, a New York-based molecular diagnostics and personalized medicine research company, has discovered a gene expression signature present in the cells of early-stage breast tumors that indicates the chance of the tumor recurring within 10 years.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXAâ„¢ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
In a breakthrough that may aid treatment of learning impairments, strokes, tinnitus and chronic pain, UT Dallas researchers have found that brain nerve stimulation accelerates learning in laboratory tests.
EpiCept Corporation has amended the exercise price of its Series A Warrants and Series B Warrants sold in June 2010 from $1.57 per share to $1.64 per share. The exercise price was amended by Amendment No.1 dated as of July 8, 2010, to the Securities Purchase Agreement between EpiCept and each of the purchasers signatory thereto, which amended the Securities Purchase Agreement dated June 25, 2010 between EpiCept and each of the purchasers signatory thereto.
Do you have difficulties remembering to do important things? A sense of everything moving too fast around you? Problems getting through the day because you just do not have the energy?
› Verified 6 days ago